MetLife Investment Management’s Smith & Wesson SWBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $440K | Buy |
29,235
+4,546
| +18% | +$68.3K | ﹤0.01% | 1981 |
|
|
2026
Q1 | $354K | Buy |
24,689
+7,038
| +40% | +$85.5K | ﹤0.01% | 1918 |
|
|
2025
Q4 | $174K | Sell |
17,651
-8,669
| -33% | -$83.7K | ﹤0.01% | 2340 |
|
|
2025
Q3 | $259K | Sell |
26,320
-3,055
| -10% | -$26.1K | ﹤0.01% | 2169 |
|
|
2025
Q2 | $255K | Hold |
29,375
| – | – | ﹤0.01% | 2055 |
|
|
2025
Q1 | $274K | Buy |
29,375
+1,967
| +7% | +$20.3K | ﹤0.01% | 2024 |
|
|
2024
Q4 | $277K | Buy |
27,408
+1,315
| +5% | +$16.5K | ﹤0.01% | 2126 |
|
|
2024
Q3 | $339K | Hold |
26,093
| – | – | ﹤0.01% | 1990 |
|
|
2024
Q2 | $374K | Buy |
26,093
+1,941
| +8% | +$31.9K | ﹤0.01% | 1889 |
|
|
2024
Q1 | $419K | Hold |
24,152
| – | – | ﹤0.01% | 1774 |
|
|
2023
Q4 | $328K | Hold |
24,152
| – | – | ﹤0.01% | 1941 |
|
|
2023
Q3 | $312K | Hold |
24,152
| – | – | ﹤0.01% | 1924 |
|
|
2023
Q2 | $315K | Hold |
24,152
| – | – | ﹤0.01% | 1981 |
|
|
2023
Q1 | $297K | Buy |
24,152
+2,825
| +13% | +$30.2K | ﹤0.01% | 1967 |
|
|
2022
Q4 | $185K | Sell |
21,327
-4,425
| -17% | -$46.6K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $267K | Buy |
25,752
+1,406
| +6% | +$18.6K | ﹤0.01% | 2106 |
|
|
2022
Q2 | $320K | Sell |
24,346
-2,343
| -9% | -$34K | ﹤0.01% | 1981 |
|
|
2022
Q1 | $404K | Buy |
26,689
+9,614
| +56% | +$162K | ﹤0.01% | 1905 |
|
|
2021
Q4 | $304K | Hold |
17,075
| – | – | ﹤0.01% | 1805 |
|
|
2021
Q3 | $354K | Hold |
17,075
| – | – | ﹤0.01% | 1729 |
|
|
2021
Q2 | $593K | Sell |
17,075
-3,961
| -19% | -$82.9K | 0.01% | 1470 |
|
|
2021
Q1 | $367K | Buy |
21,036
+1,719
| +9% | +$31.3K | ﹤0.01% | 1702 |
|
|
2020
Q4 | $343K | Sell |
19,317
-6,320
| -25% | -$105K | ﹤0.01% | 1683 |
|
|
2020
Q3 | $398K | Sell |
25,637
-7,717
| -23% | -$136K | ﹤0.01% | 1487 |
|
|
2020
Q2 | $552K | Hold |
33,354
| – | – | 0.01% | 1325 |
|
|
2020
Q1 | $213K | Hold |
33,354
| – | – | ﹤0.01% | 1667 |
|
|
2019
Q4 | $238K | Hold |
33,354
| – | – | ﹤0.01% | 1886 |
|
|
2019
Q3 | $150K | Hold |
33,354
| – | – | ﹤0.01% | 2103 |
|
|
2019
Q2 | $231K | Sell |
33,354
-66,707
| -67% | -$472K | ﹤0.01% | 1943 |
|
|
2019
Q1 | $718K | Buy |
100,061
+66,707
| +200% | +$605K | ﹤0.01% | 1857 |
|
|
2018
Q4 | $330K | Hold |
33,354
| – | – | ﹤0.01% | 1620 |
|
|
2018
Q3 | $398K | Hold |
33,354
| – | – | ﹤0.01% | 1677 |
|
|
2018
Q2 | $308K | Hold |
33,354
| – | – | ﹤0.01% | 1707 |
|
|
2018
Q1 | $265K | Hold |
33,354
| – | – | ﹤0.01% | 1744 |
|
|
2017
Q4 | $329K | Buy |
+33,354
| New | +$360K | ﹤0.01% | 1656 |
|
Other funds holding SWBI
MetLife Investment Management's SWBI Position: Q2 2026 in Review
MetLife Investment Management increased its Smith & Wesson (SWBI) stake by 18% in Q2 2026, buying an estimated $68.3K and bringing the position to 29,235 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.
MetLife Investment Management first reported a position in SWBI in Q4 2017 and has held it in 35 quarters since. The position peaked at $718K in Q1 2019. 200 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.
- MetLife Investment Management held 29,235 shares of Smith & Wesson worth $440K as of Q2 2026.
- MetLife Investment Management bought 4,546 Smith & Wesson shares in Q2 2026, an estimated $68.3K.
- Smith & Wesson made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1981 holding.
- MetLife Investment Management first reported a position in Smith & Wesson in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Smith & Wesson position peaked at $718K in Q1 2019.
- 200 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.